Venous thrombosis in children

An emerging issue

Angelo C. Molinari, Paola Saracco, Valerio Cecinati, Maurizio Miano, Emilia Parodi, Massimo Grassi, Laura Banov, Domenico De Mattia, Paola Giordano

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

More and more cases of venous thrombosis are diagnosed in children thanks to newer imaging modalities. Central venous catheters have become commonplace in the care of critically ill children and have contributed to the increased rate of thrombotic events. Lastly, children who develop life-threatening or chronic medical conditions are surviving longer because of advanced medical therapies; these intensive therapies can be complicated by events such as thrombosis. Over the last 10 years, specific guidelines for treating thrombosis in children have become available. Nevertheless, in many situations anticoagulant treatment is specially tailored to each individual patient's needs. Some new antithrombotic drugs which have undergone clinical testing in adults might be beneficial to paediatric patients with thromboembolic disorders; unfortunately, clinical data and reports on the use of these drugs in children, when available, are extremely limited. The aim of this review is to provide physicians with enough background information to be able to manage thrombosis in children. First, by helping them detect a thrombotic event in a child. Upon confirmation of the diagnosis, the physician will request the appropriate tests and will choose the best treatment on the basis of the guidelines and recommendations. Moreover, the paediatrician will have the information he or she needs to identify which children are at highest risk of acute thrombotic events and relevant long-term sequelae and, therefore, to decide on the appropriate prophylactic or pharmacologic strategy. Lastly, we would like to provide the paediatrician with information on future drugs with regard to the treatment and prophylaxis of thrombosis.

Original languageEnglish
Pages (from-to)351-361
Number of pages11
JournalBlood Coagulation and Fibrinolysis
Volume22
Issue number5
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Venous Thrombosis
Thrombosis
Pharmaceutical Preparations
Guidelines
Physicians
Therapeutics
Central Venous Catheters
Critical Illness
Anticoagulants
Pediatrics

Keywords

  • diagnosis of thrombosis
  • prophylaxis of thrombosis
  • thrombosis in the child
  • treatment of thrombosis
  • venous thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Venous thrombosis in children : An emerging issue. / Molinari, Angelo C.; Saracco, Paola; Cecinati, Valerio; Miano, Maurizio; Parodi, Emilia; Grassi, Massimo; Banov, Laura; De Mattia, Domenico; Giordano, Paola.

In: Blood Coagulation and Fibrinolysis, Vol. 22, No. 5, 07.2011, p. 351-361.

Research output: Contribution to journalArticle

Molinari, AC, Saracco, P, Cecinati, V, Miano, M, Parodi, E, Grassi, M, Banov, L, De Mattia, D & Giordano, P 2011, 'Venous thrombosis in children: An emerging issue', Blood Coagulation and Fibrinolysis, vol. 22, no. 5, pp. 351-361. https://doi.org/10.1097/MBC.0b013e3283424824
Molinari, Angelo C. ; Saracco, Paola ; Cecinati, Valerio ; Miano, Maurizio ; Parodi, Emilia ; Grassi, Massimo ; Banov, Laura ; De Mattia, Domenico ; Giordano, Paola. / Venous thrombosis in children : An emerging issue. In: Blood Coagulation and Fibrinolysis. 2011 ; Vol. 22, No. 5. pp. 351-361.
@article{5e1465b0151541e68662bfaff02774c3,
title = "Venous thrombosis in children: An emerging issue",
abstract = "More and more cases of venous thrombosis are diagnosed in children thanks to newer imaging modalities. Central venous catheters have become commonplace in the care of critically ill children and have contributed to the increased rate of thrombotic events. Lastly, children who develop life-threatening or chronic medical conditions are surviving longer because of advanced medical therapies; these intensive therapies can be complicated by events such as thrombosis. Over the last 10 years, specific guidelines for treating thrombosis in children have become available. Nevertheless, in many situations anticoagulant treatment is specially tailored to each individual patient's needs. Some new antithrombotic drugs which have undergone clinical testing in adults might be beneficial to paediatric patients with thromboembolic disorders; unfortunately, clinical data and reports on the use of these drugs in children, when available, are extremely limited. The aim of this review is to provide physicians with enough background information to be able to manage thrombosis in children. First, by helping them detect a thrombotic event in a child. Upon confirmation of the diagnosis, the physician will request the appropriate tests and will choose the best treatment on the basis of the guidelines and recommendations. Moreover, the paediatrician will have the information he or she needs to identify which children are at highest risk of acute thrombotic events and relevant long-term sequelae and, therefore, to decide on the appropriate prophylactic or pharmacologic strategy. Lastly, we would like to provide the paediatrician with information on future drugs with regard to the treatment and prophylaxis of thrombosis.",
keywords = "diagnosis of thrombosis, prophylaxis of thrombosis, thrombosis in the child, treatment of thrombosis, venous thrombosis",
author = "Molinari, {Angelo C.} and Paola Saracco and Valerio Cecinati and Maurizio Miano and Emilia Parodi and Massimo Grassi and Laura Banov and {De Mattia}, Domenico and Paola Giordano",
year = "2011",
month = "7",
doi = "10.1097/MBC.0b013e3283424824",
language = "English",
volume = "22",
pages = "351--361",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Venous thrombosis in children

T2 - An emerging issue

AU - Molinari, Angelo C.

AU - Saracco, Paola

AU - Cecinati, Valerio

AU - Miano, Maurizio

AU - Parodi, Emilia

AU - Grassi, Massimo

AU - Banov, Laura

AU - De Mattia, Domenico

AU - Giordano, Paola

PY - 2011/7

Y1 - 2011/7

N2 - More and more cases of venous thrombosis are diagnosed in children thanks to newer imaging modalities. Central venous catheters have become commonplace in the care of critically ill children and have contributed to the increased rate of thrombotic events. Lastly, children who develop life-threatening or chronic medical conditions are surviving longer because of advanced medical therapies; these intensive therapies can be complicated by events such as thrombosis. Over the last 10 years, specific guidelines for treating thrombosis in children have become available. Nevertheless, in many situations anticoagulant treatment is specially tailored to each individual patient's needs. Some new antithrombotic drugs which have undergone clinical testing in adults might be beneficial to paediatric patients with thromboembolic disorders; unfortunately, clinical data and reports on the use of these drugs in children, when available, are extremely limited. The aim of this review is to provide physicians with enough background information to be able to manage thrombosis in children. First, by helping them detect a thrombotic event in a child. Upon confirmation of the diagnosis, the physician will request the appropriate tests and will choose the best treatment on the basis of the guidelines and recommendations. Moreover, the paediatrician will have the information he or she needs to identify which children are at highest risk of acute thrombotic events and relevant long-term sequelae and, therefore, to decide on the appropriate prophylactic or pharmacologic strategy. Lastly, we would like to provide the paediatrician with information on future drugs with regard to the treatment and prophylaxis of thrombosis.

AB - More and more cases of venous thrombosis are diagnosed in children thanks to newer imaging modalities. Central venous catheters have become commonplace in the care of critically ill children and have contributed to the increased rate of thrombotic events. Lastly, children who develop life-threatening or chronic medical conditions are surviving longer because of advanced medical therapies; these intensive therapies can be complicated by events such as thrombosis. Over the last 10 years, specific guidelines for treating thrombosis in children have become available. Nevertheless, in many situations anticoagulant treatment is specially tailored to each individual patient's needs. Some new antithrombotic drugs which have undergone clinical testing in adults might be beneficial to paediatric patients with thromboembolic disorders; unfortunately, clinical data and reports on the use of these drugs in children, when available, are extremely limited. The aim of this review is to provide physicians with enough background information to be able to manage thrombosis in children. First, by helping them detect a thrombotic event in a child. Upon confirmation of the diagnosis, the physician will request the appropriate tests and will choose the best treatment on the basis of the guidelines and recommendations. Moreover, the paediatrician will have the information he or she needs to identify which children are at highest risk of acute thrombotic events and relevant long-term sequelae and, therefore, to decide on the appropriate prophylactic or pharmacologic strategy. Lastly, we would like to provide the paediatrician with information on future drugs with regard to the treatment and prophylaxis of thrombosis.

KW - diagnosis of thrombosis

KW - prophylaxis of thrombosis

KW - thrombosis in the child

KW - treatment of thrombosis

KW - venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=79960692980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960692980&partnerID=8YFLogxK

U2 - 10.1097/MBC.0b013e3283424824

DO - 10.1097/MBC.0b013e3283424824

M3 - Article

VL - 22

SP - 351

EP - 361

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 5

ER -